Trial record 41 of 191 for: "autosomal recessive cerebellar ataxia type 1" OR "Cerebellar Ataxia"
(+) Epicatechin to Treat Friedreich's Ataxia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02660112|
Recruitment Status : Active, not recruiting
First Posted : January 21, 2016
Last Update Posted : November 1, 2017
Cardero Therapeutics, Inc.
Information provided by (Responsible Party):
Ralitza Gavrilova, Mayo Clinic
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Active, not recruiting|
|Estimated Primary Completion Date :||December 2018|
|Estimated Study Completion Date :||December 2018|